What does Attovia Therapeutics, Inc. do?
Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company's products include ATTO-1310, a novel ATTOBODY-based…
What is Attovia Therapeutics, Inc.'s P/E and P/B ratio?
Attovia Therapeutics, Inc. has a P/E ratio of -5.3 and a P/B ratio of -4.55.
What is Attovia Therapeutics, Inc.'s debt-to-equity ratio?
Attovia Therapeutics, Inc. has a debt-to-equity ratio of 0.04.
How much does Attovia Therapeutics, Inc. owe compared with what it owns?
Attovia Therapeutics, Inc. owes $2.13 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Attovia Therapeutics, Inc.'s Positivity rank?
Attovia Therapeutics, Inc. is ranked #6,470 of 6,774 companies globally and #3,724 of 4,000 in United States on PositoAI, with a Positivity Score of -20,546.
Does Attovia Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Attovia Therapeutics, Inc..
Where can I read the latest news about Attovia Therapeutics, Inc.?
Recent headlines about Attovia Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Attovia Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Attovia Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.